BlackRock Group’s NEOPHOTONICS CORP NPTN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q4
$123K Buy
11,340
+1,974
+21% +$26.3K ﹤0.01% 2792
2016
Q3
$153K Buy
+9,366
New +$132K ﹤0.01% 2713
2015
Q3
Sell
-56,928
Closed -$520K 3102
2015
Q2
$520K Hold
56,928
﹤0.01% 2253
2015
Q1
$384K Hold
56,928
﹤0.01% 2290
2014
Q4
$192K Buy
56,928
+9,543
+20% +$30.5K ﹤0.01% 2538
2014
Q3
$159K Buy
47,385
+26,712
+129% +$83.4K ﹤0.01% 2504
2014
Q2
$86K Buy
+20,673
New +$109K ﹤0.01% 2622

Other funds holding NPTN

BlackRock Group's NPTN Position: Q4 2016 in Review

BlackRock Group increased its NEOPHOTONICS CORP (NPTN) stake by 21% in Q4 2016, buying an estimated $26.3K and bringing the position to 11,340 shares worth $123K. The position accounts for ﹤0.01% of the portfolio, ranked #2792.

BlackRock Group first reported a position in NPTN in Q2 2014 and has held it in 7 quarters since. The position peaked at $520K in Q2 2015. 127 funds tracked by Wall St. Rank hold NPTN as of Q4 2016.

  • BlackRock Group held 11,340 shares of NEOPHOTONICS CORP worth $123K as of Q4 2016.
  • BlackRock Group bought 1,974 NEOPHOTONICS CORP shares in Q4 2016, an estimated $26.3K.
  • NEOPHOTONICS CORP made up ﹤0.01% of BlackRock Group's portfolio in Q4 2016, its #2792 holding.
  • BlackRock Group first reported a position in NEOPHOTONICS CORP in Q2 2014 and has held it in 7 quarters since.
  • BlackRock Group's NEOPHOTONICS CORP position peaked at $520K in Q2 2015.
  • 127 funds tracked by Wall St. Rank held NEOPHOTONICS CORP as of Q4 2016.

Based on BlackRock Group's 13F filing for Q4 2016, filed 10 Feb 2017.